Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
March 3, 2026
A High-Throughput Screening Assay for mRNA Therapeutic Vaccines.
AS
Anson Snow
University of North Carolina at Chapel Hill
KM
Karen McKinnon
KR
Kathleen Ready
See all
Key Points
This high-throughput screening assay identifies potential mRNA therapeutics for vaccine development—significantly improving candidate evaluation.
The system screened various mRNA constructs, successfully pinpointing several potent candidates among the tested 50.
The approach involves innovative techniques to enhance the efficiency of vaccine candidate identification, ensuring rapid analysis.
Such advancements may expedite the delivery of effective mRNA vaccines, promoting swift public health responses to infectious diseases.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Snow et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7609fc6e9836116a2d8dd
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.160
A High-Throughput Screening Assay for mRNA Therapeutic Vaccines. | Synapse